Skip to content

A study conducted on HIV patients to check their drug treatment, any unexpected reactions related to the treatment, to look for mental illness like saddnes,tension.

Evaluation of impact of depression and its association to highly active antiretroviral therapy adherence and adverse drug reactions in people living with HIV

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/10/010230
Enrollment
200
Registered
2017-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HIV Associated Depression Patients

Interventions

Control Intervention1: 1) Group 1 will consist of HIV-positive patients receiving HAART with depression (Cases). 2) Group 2 will consist of HIV-positive receiving HAART without depression (Controls).:

Sponsors

Kasturba medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HIV- seropositive patients (HIV-SPP) above 18 years of age, hospitalized in- patients and out patients of either sex receiving HAART and HIV-SPP receiving HAART with symptoms of HIV associated depression will be included.

Exclusion criteria

Exclusion criteria: HIV-SPP receiving HAART who refused for medication adherence and depression assessment interview, patients with traditional medicines alone, pregnant women, HIV-SPP with chronic kidney disease, rheumatoid arthritis, cancer patients, psychiatric co-morbidities, systemic lupus erythematosus, and patients with surgery within last three months will be excluded.

Design outcomes

Primary

MeasureTime frame
Severity of depression outcomes, HAART adherence outcomes and ADRs outcomes will be assessed and documented.Timepoint: Clinical data collection of the patient will be done at the time of their hospital visit. Study will be done within 8 months of period.

Secondary

MeasureTime frame
HAART Adherence and ADRs outcomes will be assessed and documented.Timepoint: Clinical data collection of the patient will be done at the time of their hospital visit. Study will be done within 8 months of period

Countries

India

Contacts

Public Contactchinnu p roy
rrajesh3775@gmail.com9448374166

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026